🔗 Share this article

This year's Nobel Prize in medical science was granted for transformative findings that illuminate how the immune system attacks dangerous pathogens while sparing the healthy tissues.

A trio of esteemed researchers—Japan's Shimon Sakaguchi and US experts Mary Brunkow and Dr. Ramsdell—received this accolade.

The research uncovered specialized "sentinels" within the defense system that eliminate rogue defense cells capable of harming the body.

These findings are now paving the way for innovative therapies for immune disorders and malignancies.

These laureates will share a prize fund worth 11m Swedish kronor.

Decisive Findings

"Their work has been essential for comprehending how the immune system functions and why we don't all develop severe autoimmune diseases," commented the head of the Nobel Committee.

The trio's research explain a fundamental mystery: How does the defense system defend us from numerous infections while leaving our own tissues unharmed?

Our body's protection system employs immune cells that search for signs of infection, even viruses and germs it has not met before.

Such cells utilize sensors—known as receptors—that are produced randomly in countless combinations.

This gives the immune system the ability to combat a wide array of invaders, but the randomness of the mechanism inevitably creates immune cells that can target the host.

Protectors of the Body

Researchers earlier knew that a portion of these problematic white blood cells were eliminated in the immune organ—where immune cells mature.

This year's Nobel Prize recognizes the identification of regulatory T-cells—described as the immune system's "peacekeepers"—which patrol the body to neutralize other defenders that attack the healthy cells.

We know that this process fails in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

The prize committee added, "These discoveries have laid the foundation for a novel area of investigation and spurred the development of innovative therapies, for example for cancer and immune disorders."

In malignancies, T-regs block the system from attacking the growth, so research are focused on reducing their quantity.

For autoimmune diseases, experiments are exploring increasing regulatory T-cells so the body is not being harmed. A similar approach could also be useful in minimizing the risks of transplanted organ failure.

Pioneering Studies

Professor Shimon Sakaguchi, from a Japanese institution, conducted experiments on mice that had their thymus extracted, causing self-attack conditions.

The researcher showed that introducing defense cells from other animals could stop the disease—suggesting there was a mechanism for preventing immune cells from harming the body.

Dr. Brunkow, affiliated with the Institute for Systems Biology in a US city, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were investigating an genetic immune disorder in rodents and people that resulted in the discovery of a genetic factor vital for the way T-regs operate.

"The pioneering work has uncovered how the immune system is controlled by T-reg cells, stopping it from mistakenly attacking the healthy cells," said a prominent biological science specialist.

"The work is a striking illustration of how basic physiological research can have broad implications for public health."